Anthera Pharmaceuticals, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2016. For the quarter, the company's loss from operations was $14,281,000 compared to $8,846,000 a year ago. Net loss was $14,334,000 or $0.35 per basic and diluted share compared to $8,895,000 or $0.25 per basic and diluted share a year ago. For the six months, the company's total revenues were $145,000 compared to $534,000 a year ago. Loss from operations was $25,998,000 compared to $16,503,000 a year ago. Net loss was $26,060,000 or $0.64 per basic and diluted share compared to $16,555,000 or $0.52 per basic and diluted share a year ago.